1

Director Investor Relations Biotech Jobs (NOW HIRING)

Director, Investor Relations

Waltham, MA · Hybrid

$188K - $235K/yr

Zenas BioPharma is seeking an accomplished Director of Investor Relations to lead the development ... biotechnology or the life sciences; experience in a publicly traded biotech company strongly ...

Director, Investor Relations We are looking for a Director, Investor Relations to help shape how we communicate our performance, strategy, and long-term value creation. In this role, you will take a ...

Director, Investor Relations

Seattle, WA · On-site

$207.50 - $290.50/hr

Director, Investor Relations At Expedia Group, we help travelers explore the world, one journey at a time. As a global travel company powered by passionate people, trusted partnerships, and leading ...

New

Director, Investor Relations

Seattle, WA · On-site

$207.50 - $290.50/hr

Director, Investor Relations We are looking for a Director, Investor Relations to help shape how we communicate our performance, strategy, and long-term value creation. In this role, you will take a ...

Director, Investor Relations

Seattle, WA · On-site

$207.50 - $290.50/hr

Director, Investor RelationsWe are looking for a Director, Investor Relations to help shape how we communicate our performance, strategy, and long-term value creation.In this role, you will take a ...

New

As a Director, Investor Relations at Honeywell, you will play a crucial role in strengthening our relationships with the investment community, facilitating communication, and helping to shape our ...

As a Director, Investor Relations at Honeywell, you will play a crucial role in strengthening our relationships with the investment community, facilitating communication, and helping to shape our ...

Summary Reporting to the Vice President, Corporate Development & Capital Markets, the Director, Investor Relations is a senior member of Enerflex's Corporate Finance function and plays a key role in ...

As a Director, Investor Relations at Honeywell, you will play a crucial role in strengthening our relationships with the investment community, facilitating communication, and helping to shape our ...

The Director of Investor Relations will provide strategic guidance and serve as an advisor to the company on the Investor Relations program. This role will engage, interface and influence with a ...

next page

Showing results 1-20

Director Investor Relations Biotech information

See salary details

$52.5K

$146.1K

$247K

How much do director investor relations biotech jobs pay per year?

As of Aug 3, 2026, the average yearly pay for director investor relations biotech in the United States is $146,114.00, according to ZipRecruiter salary data. Most workers in this role earn between $99,500.00 and $195,000.00 per year, depending on experience, location, and employer.

What skills and qualifications are needed to thrive as a director of investor relations in biotech?

To thrive as a Director of Investor Relations in Biotech, you need a deep understanding of biotechnology, finance, and capital markets, typically supported by a degree in finance, business, or life sciences and several years of relevant experience. Familiarity with financial reporting tools, investor relations software, and regulatory systems such as SEC filings is essential. Exceptional communication, strategic thinking, and relationship-building skills are crucial for effectively engaging investors and representing the company's value proposition. These skills ensure transparent and compelling communications with stakeholders, fostering trust and supporting the company's access to capital and growth.

How does a director of investor relations in biotech collaborate with scientific and executive teams to communicate complex information to investors?

A Director of Investor Relations in biotech works closely with scientific leaders and executive management to translate complex research, clinical trial progress, and regulatory milestones into clear, compelling messages for investors. This collaboration involves regular meetings to stay updated on scientific developments, preparing presentations and press releases, and coaching executives for investor meetings. The goal is to ensure that both the financial and scientific aspects of the company are accurately represented, helping investors understand the value and potential of the company’s pipeline and strategy.

What does a director of investor relations do in biotech?

A Director of Investor Relations in a biotech company is responsible for managing communication between the company’s leadership, its investors, and the financial community. They help to explain the company’s financial performance, research pipeline, and strategic goals to current and potential investors. This role often involves preparing earnings calls, investor presentations, and regulatory filings, as well as responding to investor inquiries. Their work is crucial for maintaining investor confidence and supporting the company’s access to capital.
More about Director Investor Relations Biotech jobs
What cities are hiring for Director Investor Relations Biotech jobs? Cities with the most Director Investor Relations Biotech job openings:
What states have the most Director Investor Relations Biotech jobs? States with the most job openings for Director Investor Relations Biotech jobs include:
Infographic showing various Director Investor Relations Biotech job openings in the United States as of July 2026, with employment types broken down into 2% As Needed, 89% Full Time, 1% Part Time, 1% Temporary, 6% Contract, and 1% Summer. Highlights an 82% Physical, 3% Hybrid, and 15% Remote job distribution, with an average salary of $146,114 per year, or $70.2 per hour.

Associate Director, Investor Relations

Beam Therapeutics

Cambridge, MA • On-site

Other

Re-posted 15 days ago


Job description

Position Overview:

Beam is seeking a highly motivated and strategic Associate Director, Investor Relations to join our growing Investor Relations and External Communications team at a pivotal moment in the company's evolution. In this role, you will support the execution of Beam's investor relations strategy and play a central part in shaping how Beam's science, pipeline, and corporate narrative are communicated to the investment community. You will partner closely with senior leadership, finance, legal, corporate communications, and program teams to translate complex clinical and scientific milestones into clear, compelling, investor-ready messaging across earnings cycles, conferences, and one-on-one engagements. This position is critical to building a best-in-class IR function as Beam transitions from a clinical-stage to commercial-stage biotechnology company delivering on the promise of base editing for patients with serious diseases.

Key Responsibilities:

  • Support execution of Beam's investor relations strategy, including proactive engagement with buy-side and sell-side investors.
  • Help manage investor targeting, outreach, and meeting coordination for one-on-ones, conferences, and non-deal roadshows.
  • Track investor sentiment, ownership trends, and peer activity to inform outreach strategy and positioning.
  • Serve as a secondary point of contact for inbound investor and analyst inquiries.
  • Support continuous improvement of IR best practices and infrastructure.
  • Support preparation of key disclosures and quarterly earnings materials, including scripts, slide decks, Q&A documents, and press releases.
  • Help ensure accuracy, consistency, and compliance across external disclosures in coordination with legal and finance.
  • Manage internal consensus models.
  • Work cross-functionally with R&D, Clinical Development, Regulatory, and Commercial teams to: stay current on program updates and key milestones; translate technical data into clear, investor-relevant narratives; and support investor-facing materials related to clinical data readouts, regulatory updates, and pipeline evolution.
  • Help refine and maintain Beam's corporate narrative as the company evolves from a clinical-stage to commercial-stage biotech.
  • Assist in message testing and preparation of executive spokespeople.
  • Manage updates to Beam's investor website and coordinate with Corporate Communications on broader digital and website strategy and content.

Required Qualifications:

  • 5-8 years of experience in investor relations, equity research, investment banking, corporate finance, or strategic communications, with meaningful exposure to public biotechnology or life sciences companies.
  • Strong understanding of capital markets, public company disclosure requirements, and investor expectations.
  • Ability to synthesize complex scientific, clinical, and financial information into clear, concise messaging.
  • Proven written and verbal communication skills.
  • High attention to detail and strong project management capabilities.
  • Comfortable operating in a fast-paced, highly cross-functional environment.
  • Ability to travel as needed to support business objectives, conferences, and company events.

Preferred Qualifications:

  • Prior experience supporting a pipeline-driven biotech company with multiple clinical programs.
  • Exposure to companies approaching or undergoing a transition to commercial stage.
  • Familiarity with gene editing, genetic medicine, or other advanced therapeutic modalities.
  • Experience interacting directly with investors or analysts.